gliclazide has been researched along with Infant, Newborn, Diseases in 2 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelty, E | 1 |
| Tran, DD | 1 |
| Atkinson, A | 1 |
| Preen, DB | 1 |
| Havard, A | 1 |
| Cho, JH | 1 |
| Kang, E | 1 |
| Lee, BH | 1 |
| Kim, GH | 1 |
| Choi, JH | 1 |
| Yoo, HW | 1 |
2 other studies available for gliclazide and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Maternal and Neonatal Health Outcomes Associated with the Use of Gliclazide and Metformin for the Treatment of Diabetes in Pregnancy: A Record Linkage Study.
Topics: Abnormalities, Drug-Induced; Adult; Diabetes, Gestational; Female; Gliclazide; Hospitalization; Huma | 2020 |
DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea.
Topics: Base Sequence; Brain; Diabetes Mellitus; DNA; Epilepsy; Gliclazide; Glycated Hemoglobin; Heterozygot | 2017 |